← Evidence map

ArticleAdvances in rheumatology (London, England)2024

Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics.

Oh Chan Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics. | OpenQuestion